Responses
Regular and young investigator award abstracts
Immune-stimulants and immune modulators
572 Fibroblast activating protein (FAP)-targeting IL-12 (anti-FAP/IL-12) TMEkine™ potentiates anti-cancer effects in preclinical cancer models
Compose a Response to This Article
Other responses
No responses have been published for this article.
